Cargando…

CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic systematicness autoimmunity disease with joint inflammation. RA etiology is still unknown. Early and exact diagnosing is still hard to reach. In the paper, we purposed to discover novel diagnosis biological marker for RA. Two open, usable gene expression profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhi-wen, Zhang, Li-jun, Zhuang, Yu, Lv, Zhi-fen, Tan, Zhi-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250429/
https://www.ncbi.nlm.nih.gov/pubmed/35789606
http://dx.doi.org/10.1155/2022/2431976
_version_ 1784739809508458496
author Wang, Zhi-wen
Zhang, Li-jun
Zhuang, Yu
Lv, Zhi-fen
Tan, Zhi-ming
author_facet Wang, Zhi-wen
Zhang, Li-jun
Zhuang, Yu
Lv, Zhi-fen
Tan, Zhi-ming
author_sort Wang, Zhi-wen
collection PubMed
description Rheumatoid arthritis (RA) is a chronic systematicness autoimmunity disease with joint inflammation. RA etiology is still unknown. Early and exact diagnosing is still hard to reach. In the paper, we purposed to discover novel diagnosis biological marker for RA. Two open, usable gene expression profiles of human RA as well as controlled specimens (dataset GSE17755 as well as GSE93272) were downloaded from the GEO database. Differentially expressed genes (DEGs) were screened between 331 RA and 88 control samples. Functional enrichment analysis was applied to explore the possible function of DEGs. Expression levels as well as diagnosis values of biological marker in RA were further verified in our cohort by the use of RT-PCR and ROC assays. We identified 13 DEGs between RA samples and control samples. 13 DEGs were remarkably abundant in NF-kappa B signal pathway. Among the 13 DEGs, CKS2, S100A12, LY96, and ANXA3 exhibited a strong diagnostic ability in screening RA specimens from normal specimens using all AUC > 0.8. Moreover, we confirmed that the expression of CKS2 and S100A12 was distinctly upregulated in RA specimens contrasted to normal specimens. Overall, serum CKS2 and S100A12 could be used as novel diagnosis biological markers for RA patients.
format Online
Article
Text
id pubmed-9250429
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92504292022-07-03 CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis Wang, Zhi-wen Zhang, Li-jun Zhuang, Yu Lv, Zhi-fen Tan, Zhi-ming Dis Markers Research Article Rheumatoid arthritis (RA) is a chronic systematicness autoimmunity disease with joint inflammation. RA etiology is still unknown. Early and exact diagnosing is still hard to reach. In the paper, we purposed to discover novel diagnosis biological marker for RA. Two open, usable gene expression profiles of human RA as well as controlled specimens (dataset GSE17755 as well as GSE93272) were downloaded from the GEO database. Differentially expressed genes (DEGs) were screened between 331 RA and 88 control samples. Functional enrichment analysis was applied to explore the possible function of DEGs. Expression levels as well as diagnosis values of biological marker in RA were further verified in our cohort by the use of RT-PCR and ROC assays. We identified 13 DEGs between RA samples and control samples. 13 DEGs were remarkably abundant in NF-kappa B signal pathway. Among the 13 DEGs, CKS2, S100A12, LY96, and ANXA3 exhibited a strong diagnostic ability in screening RA specimens from normal specimens using all AUC > 0.8. Moreover, we confirmed that the expression of CKS2 and S100A12 was distinctly upregulated in RA specimens contrasted to normal specimens. Overall, serum CKS2 and S100A12 could be used as novel diagnosis biological markers for RA patients. Hindawi 2022-06-25 /pmc/articles/PMC9250429/ /pubmed/35789606 http://dx.doi.org/10.1155/2022/2431976 Text en Copyright © 2022 Zhi-wen Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Zhi-wen
Zhang, Li-jun
Zhuang, Yu
Lv, Zhi-fen
Tan, Zhi-ming
CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
title CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
title_full CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
title_fullStr CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
title_full_unstemmed CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
title_short CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
title_sort cks2 and s100a12: two novel diagnostic biomarkers for rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250429/
https://www.ncbi.nlm.nih.gov/pubmed/35789606
http://dx.doi.org/10.1155/2022/2431976
work_keys_str_mv AT wangzhiwen cks2ands100a12twonoveldiagnosticbiomarkersforrheumatoidarthritis
AT zhanglijun cks2ands100a12twonoveldiagnosticbiomarkersforrheumatoidarthritis
AT zhuangyu cks2ands100a12twonoveldiagnosticbiomarkersforrheumatoidarthritis
AT lvzhifen cks2ands100a12twonoveldiagnosticbiomarkersforrheumatoidarthritis
AT tanzhiming cks2ands100a12twonoveldiagnosticbiomarkersforrheumatoidarthritis